Drug Channels Outlook 2025
Drug Channels Outlook 2025
Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for DCI’s new live video webinar:
Drug Channels Outlook 2025
This event will be broadcast live on
Friday, December 13, 2024,
from 12:00 p.m. to 1:30 p.m. ET
This page describes the event and explains how to purchase a registration. Jump to pricing options. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia.
This event is part of The Drug Channels 2024 Video Webinar Series.
WHAT YOU WILL LEARN
Join Dr. Fein as he helps you and your team get ready for 2025 by outlining key issues and uncertainties that will surely affect your planning. This event can be both a capstone of your annual learning and a touchpoint for the future. DCI’s Outlook webinars have proven to be reliable and informative guides to crucial aspects of the ever-evolving healthcare industry.
During the event, Dr. Fein will share his latest thinking and projections on a wide range of topics, including:
- Latest predictions for the Inflation Reduction Act
- Expectations for the Medicare Part D market in 2025 and beyond
- Update on 340B Drug Pricing Program’s controversies
- Vertical integration and consolidation trends—and prospects for dis-integration and de-consolidation
- The state of biosimilar markets
- What’s next for PBMs’ private label products and GPOs
- Retail pharmacy’s future
- Prospects for direct-to-patient channels
- What’s ahead for discount cards and cash-pay pharmacies
- The outlook for state and federal legislation on PBMs and the drug channel
- Gross-to-net bubble developments
- Likely policy actions by the new administration and Congress
- Update on accumulators, maximizers, and alternative funding
- And much more!
PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will last at least 90 minutes to accommodate audience questions.
As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data. He will draw from exclusive information found in DCI’s economic reports .
Read on for full details on pricing and registration.
PRICING OPTIONS
You can register for this unique educational opportunity for only $400 per viewing device. Within 24 hours of your purchase, you will receive an email from Zoom with a unique link to access the event and add it to your calendar.
We are offering substantial discounts for multiple registrations from the same organization. We know that many of you are now working remotely, so rates for multiple registrations are as low as $280 per device—a 30% savings. An unlimited number of people may watch at one physical location if they can watch from a single device. Please note that a device at a single physical location may not record, stream, share, or project our webinar to other sites, devices, or locations. Each device at a physical location requires its own registration.
Click here to order. All discounts will be automatically computed based on the number of registrations you enter in your cart. (You can reset the cart by entering 0 in the quantity field.)
Drug Channels Outlook 2025ORDER
(You can reset the cart by entering 0 in the quantity field.)
Please contact Paula Fein (paula@drugchannels.net) if you have any questions. If you purchase access for multiple devices, we will contact you for a list of your participants and their email addresses. Or, download this spreadsheet and email your registrants’ information to dcisupport@hmpglobal.com.
Payment can be made with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal. Click here to email us if you would like to pay by corporate purchase order or check.
IMPORTANT THINGS TO KNOW
- Watch and listen via any device with a web browser (computer, iPad, iPhone/Android, etc.) There is no access via telephone.
- We will use Zoom technology for this webinar. Every registrant will receive an email from Zoom with a link to watch the event. This link is unique to the registrant and can only be accessed once. We recommend that every registrant download the Zoom client software/app.
- Every registrant will receive an email from Zoom with links to download Dr. Fein’s slides.
- Every registrant—whether they attend the live Zoom event or not—will have an opportunity to view a full replay of the event and download Dr. Fein’s slides.
- This event is part of The Drug Channels 2024 Video Webinar Series. If you already purchased access to the 2024 Drug Channels Video Webinar Series, then you should have received an email from Zoom with a link to access the December 13 event.
- If you purchase the 2024 webinar series now, then within 24 hours of purchasing the 2024 series, you will receive an email from Zoom with links to access a replay video and the complete slide deck from (1) Drug Channel Implications of the Inflation Reduction Act, and (2) The 340B Drug Pricing Program: Trends, Controversies, and Outlook. You will also be automatically registered for our Outlook 2025 webinar on December 13, 2024.
- Organizations that purchased corporate access for The Drug Channels 2024 Video Webinar Series will receive a custom, branded signup link so employees can easily register. We will automatically refund payments from anyone at a company with corporate access who purchases a single registration using their corporate email account.
- Each registration for a DCI webinar is valid for a single device at a single physical location. Each device at a physical location requires its own registration. Attendees are not permitted to record, stream, share, or project a DCI webinar to other sites or locations. Purchasers who violate this limitation by recording, streaming, sharing, or projecting a DCI webinar to other sites, devices, or locations will be liable for the full cost of all locations that viewed the webinar. DCI reserves the right to prohibit purchasers who violate our terms from attending future DCI webinars.
- Unfortunately, we are unable to offer refunds.